Takeda Pharmaceutical Company Limited
TAK institutional ownership changes in Q2 2026: 80 institutions opened or added positions, 50 trimmed or exited. TAK (Takeda Pharmaceutical Company Limited) is held by 129 institutional investors as of Q2 2026. Top institutional shareholders: Capital Research Global Investors ($309.3M), FMR LLC ($153.9M), Morgan Stanley ($112.1M). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Nov 5, 2026 · Activists none · Congress Jul 21, 2026
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 19.3M(+1.0%) | $309.3M | 0.0% | +30.05% | 31 | |
Increased | 9.6M(+34.9%) | $153.9M | 0.0% | +30.12% | 39 | |
Increased | 7M(+8.1%) | $112.1M | 0.0% | +55.00% | 33 | |
Decreased | 6.1M(-5.8%) | $97M | 0.1% | +13.50% | 0 | |
Decreased | 5.1M(-8.8%) | $82.2M | 0.0% | +45.73% | 0 | |
Increased | 4.5M(+2.5%) | $72.8M | 0.5% | +38.89% | 43 | |
Increased | 3.7M(+19.8%) | $59.8M | 0.0% | +39.16% | 35 | |
Increased | 3.7M(+16.1%) | $59.1M | 0.0% | +39.43% | 34 | |
Decreased | 2.6M(-14.1%) | $41.2M | 0.1% | +38.36% | 0 | |
New | 2.2M | $35.4M | 0.0% | +31.13% | 40 | |
Increased | 2.1M(+7.3%) | $33.9M | 0.0% | +49.85% | 31 | |
Decreased | 2M(-21.3%) | $32.9M | 0.0% | +35.37% | 0 | |
Decreased | 1.7M(-11.3%) | $27.9M | 0.0% | +23.55% | 0 | |
Increased | 1.6M(+13.2%) | $25.6M | 0.0% | +30.68% | 32 | |
Increased | 1.5M(+70.6%) | $24.5M | 0.0% | +33.57% | 43 | |
Increased | 1.4M(+8.8%) | $22.5M | 0.0% | +38.50% | 31 | |
Increased | 1.2M(+1.3%) | $18.4M | 0.0% | +33.06% | 29 | |
New | 1.1M | $16.8M | 0.0% | +31.13% | 39 | |
Decreased | 911,319(-66.7%) | $14.6M | 0.0% | +45.02% | 0 | |
Increased | 744,916(+64.1%) | $11.9M | 0.0% | +29.44% | 41 |
Showing 1-20 of 138
| Insider | Trade | Traded |
|---|---|---|
| Platford Giles Richard | Sell $1.2M | |
| Bitetti Teresa Marie | Sell $974K | |
| Duprey Lauren Rusckowski | Sell $640K | |
| Plump Andrew Stewart | Sell $2.1M | |
| Plump Andrew Stewart | Sell $363K | |
| Greenway Nicola Deidre Petal | Sell $235K | |
| Shannon Elaine Mary | Sell $357K | |
| Platford Giles Richard | Sell $532K | |
| Plump Andrew Stewart | Sell $2.8M | |
| Kim Julie So-Young | Sell $1.5M |
| Member | Trade | Traded |
|---|---|---|
| Alan Armstrong | Buy $1,001 - $15,000 |
TAKTakeda Pharmaceutical Company LimitedContinue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about TAK
Who owns TAK?
129 institutional investors held TAK on June 30, 2026, led by Capital Research Global Investors ($309.3M), FMR LLC ($153.9M) and Morgan Stanley ($112.1M).
How many hedge funds hold TAK?
129 institutional investors reported TAK in their 13F filings for the quarter ended June 30, 2026, $1.5B in all. 7 of them are rated Elite.
Are institutions buying or selling TAK?
Buying, on balance. In Q2 2026, 80 institutions opened or added to positions in TAK and 50 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer